Tay-Sachs Disease Drug Pipeline Analysis
Tay-Sachs disease is a rare genetic central nervous system disorder that results from a deficiency of the enzyme hexosaminidase A (Hex-A), which leads to the accumulation of harmful substances in the brain and nervous system. Studies reveal that approximately 1 in every 320,000 babies born is affected by Tay-Sachs disease in the United States, with the disorder being more prevalent in certain...
0 Kommentare
0 Anteile